Shanghai East Hospital, Tongji University
Shanghai East Hospital, Tongji University
Shanghai, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Recruiting | Phase 2 | 2026-08-12 | NCT07697586 | |
| A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2026-05-08 | NCT06448312 | |
| Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV) | cardiovascular disorder | Enrolling by invitation | Not applicable | 2026-01-06 | NCT04444362 |